CARY, N.C.--(BUSINESS WIRE)--SynopiaRx today announced that it has partnered with Iroko Pharmaceuticals, LLC to manage the company’s access plan for its investigational nonsteroidal anti-inflammatory drugs (NSAIDs) currently in late-stage clinical development. SynopiaRx provides expertise in payer insights, strategy development and account management for pharmaceutical companies navigating the managed care landscape to help ensure that their therapies are available and accessible to patients.
